Journal:
:international journal of hematology-oncology and stem cell research
0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran
mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran
ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran
mahdi zahed panah school of allied medical sciences, qazvin university of medical sciences, qazvin, iran
mohammad reza ostadali hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran
hajar nasiri hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran
background: mesenchymal stromal cells (mscs) are employed in various different clinical settings in order to modulate immune response. human autologous and allogeneic supplements including platelet derivatives such as platelet lysate (pl), platelet-released factors (prf) and serum are assessed in clinical studies to replace fetal bovine serum (fbs). the immunosuppressive activity and multi-pote...